HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kodama, I Articles by Shibata, S Search for Related Content PubMed PubMed Citation Articles by Kodama, I Articles by Shibata, S

Okadaic acid is a monocarboxylic acid with a unique molecular structure of C44H66O13. Okadaic acid, at concentrations above 10(-5) M, caused a dose-dependent increase of contractile force in guinea-pig isolated ventricular muscles. The increase of contractile force by okadaic acid (1-4 X 10(-5) M) was accompanied by a prolongation of action potential duration (a.p.d.), while a.p.d. was shortened by okadaic acid at above 10(-4) M. The okadaic-acid-induced changes in contractile force and a.p.d. were abolished by pre-treatment with verapamil (2 X 10(-6 M) or nifedipine (10(-6) M). In a low-Ca2+ medium (0.12 mM), the contractile response to okadaic acid (4 X 10(-5) M) was inhibited, whereas the a.p.d. was more prolonged by the drug than in a control medium (containing 1.2 mM-Ca2+). In a low-Na+ (70 mM) medium or in a low-Na+ (70 mM) and low-Ca2+ (0.12 mM) medium both the contractile force and a.p.d. were unaffected by okadaic acid (4 X 10(-5) M). The positive inotropic effect of okadaic acid (4 X 10(-5) M) was not inhibited by treatment with tetrodotoxin (TTX, 2 X 10(-6) M) or with ryanodine (2 X 10(-6) M). In voltage-clamp experiments using a single sucrose-gap technique, okadaic acid (4 X 10(-5) M), caused a significant increase of slow inward current, while it did not affect the net outward current. These findings suggest that okadaic acid has a positive inotropic effect on the heart, probably due to the enhancement of slow Ca2+ and/or Na+ inward current through the cell membrane.

This article has been cited by other articles:

				N. Brewis, K. Ohst, K. Fields, A. Rapacciuolo, D. Chou, C. Bloor, W. Dillmann, H. Rockman, and G. Walter Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1307 - H1318. [Abstract] [Full Text] [PDF]

				J. Knapp, P. Bokník, I. Lüss, S. Huke, B. Linck, H. Lüss, F. U. Müller, T. Müller, P. Nacke, T. Noll, et al. The Protein Phosphatase Inhibitor Cantharidin Alters Vascular Endothelial Cell Permeability J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1480 - 1486. [Abstract] [Full Text]